Search

everythinglearnresearchcommunity

for

Search:↓

Reduced AR gene methylation may cause early pubic hair growth in girls.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

AR gene not major factor in female hair loss; different from male hair loss.

Hair loss from genetics and hormones can be treated with drugs or surgery.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Alternative treatments show promise for hair growth beyond traditional methods.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.